Tag

Regenerative Medicine

All articles tagged with #regenerative medicine

Shin Tapping May Heal Brain Injuries via Bone Protein Signal
science16 days ago

Shin Tapping May Heal Brain Injuries via Bone Protein Signal

Researchers at Southern Medical University discovered that rhythmic tapping on the shin bones of mice and pigs with brain injuries can accelerate neural recovery. The study, published in Nature Neuroscience, shows that this mechanical stimulation reduces cell loss, promotes neuron growth, and improves motor function. The healing effect relies on the PIEZO1 protein in bone cells, which opens ion channels in response to pressure, sending signals to the brain. Animals lacking this protein showed no benefits, confirming the bone-to-brain communication pathway.

Flatworm Gene Map Offers New Path for Human Brain Repair
science18 days ago

Flatworm Gene Map Offers New Path for Human Brain Repair

University of Georgia researchers identified a genetic blueprint in planarian flatworms that allows them to regenerate dopamine-producing neurons after injury. This discovery suggests that human brain repair limitations are not inherent to neural tissue but may be due to specific regulatory switches, offering a potential roadmap for future therapies for Parkinson's disease and traumatic brain injuries.

Cell Therapy Trial Shows 94% Drop in Osteoporosis Fractures
health20 days ago

Cell Therapy Trial Shows 94% Drop in Osteoporosis Fractures

A Phase 1 trial involving 10 women with severe osteoporosis demonstrated a 94% reduction in fractures after receiving autologous mesenchymal stromal cells modified to target bone tissue. While the study was primarily designed to assess safety, results indicated improved bone structure and fewer breaks, suggesting potential for future regenerative treatments.

Zurich researchers report stem cell transplants restore motor function in stroke-affected mice
science-and-health20 days ago

Zurich researchers report stem cell transplants restore motor function in stroke-affected mice

University of Zurich scientists found that transplanting human neural stem cells into the brains of mice one week after a stroke induced new neuron growth, repaired blood vessels, and restored movement. The study suggests a potential path for regenerative treatments, though significant hurdles remain before human trials.

Engineered Stem Cells Cut Fracture Rates by 94% in Osteoporosis Trial
health27 days ago

Engineered Stem Cells Cut Fracture Rates by 94% in Osteoporosis Trial

A phase 1 trial published in Cell reports that a modified autologous stem cell therapy significantly reduced fragility fractures in patients with advanced osteoporosis. The treatment, which involved editing the surface of mesenchymal stem cells to improve their ability to return to bone marrow, showed a 94% drop in fracture incidence and increased bone density in a small cohort of women.

Tweaked marrow cells hint at rebuilding brittle bones in osteoporosis
science1 month ago

Tweaked marrow cells hint at rebuilding brittle bones in osteoporosis

Ten women with advanced osteoporosis received autologous bone-marrow–derived mesenchymal cells engineered to improve bone-homing; after a single infusion, fracture rates dropped dramatically and stayed low for years, suggesting a potential one-time regenerative therapy, though the study was small, lacked a control group, and participants were on standard osteoporosis drugs, requiring larger randomized trials.

Stem-Cell Patch Rebuilds Cornea, Boosts Vision in Rare Eye Disorder
health1 month ago

Stem-Cell Patch Rebuilds Cornea, Boosts Vision in Rare Eye Disorder

A JAMA Ophthalmology study reports RAFT-OS, a collagen scaffold graft that combines surface stem cells with healthy stromal keratocytes to treat aniridia-related keratopathy. Transplanted to one eye, this approach addresses the damaged environment needed for stem cells to survive. By 3 months, five of nine treated eyes had fully normalized corneal surfaces; by 12 months, treated eyes showed dramatic surface improvement while untreated eyes did not. Participants gained nearly five lines on the ETDRS chart. The technique could enable further treatments and be applied to other severe corneal surface diseases, but larger, longer-term trials and cost/regulatory hurdles remain.

Blocking 15-PGDH May Rebuild Aging Cartilage and Ease Osteoarthritis
science1 month ago

Blocking 15-PGDH May Rebuild Aging Cartilage and Ease Osteoarthritis

Stanford researchers identify the enzyme 15-PGDH as a key aging brake on cartilage repair. In mice, inhibiting 15-PGDH thickened worn cartilage and prevented arthritis after joint injury; human cartilage samples showed similar improvements, suggesting a potential new therapy for aging- and injury-related osteoarthritis. The work is part of broader ARPA-H/NITRO efforts with clinical trials planned, and does not rely on stem cells, instead reactivating existing cartilage cells.

Gentle stem-cell transplant hints at rejuvenating aging blood and immunity in mice
science2 months ago

Gentle stem-cell transplant hints at rejuvenating aging blood and immunity in mice

A study in mice shows that transplanting young, lab-expanded blood-forming stem cells into aged animals—without chemotherapy or radiation—restores blood production and rebirths of immune cells (naive B and T cells), effectively reshaping the aging immune system. While the approach worked in mice and used a gentler method (including targeted helpers to spare healthy cells), it is far from clinical use in humans and faces safety, regulatory, and scalability hurdles; nonetheless, experts see potential for future therapies that renew the body’s blood-forming system rather than wide-ranging anti-aging cures.

New Life After Death: Cells Reorganize into Xenobots and Anthrobots
science2 months ago

New Life After Death: Cells Reorganize into Xenobots and Anthrobots

Scientists report a 'third state' between life and death: cells from deceased organisms can form new, functioning multicellular units called Xenobots (frog cells) and Anthrobots (human cells) that move, repair damage, and even reorganize without normal growth, suggesting an electrical toolkit that rewrites cellular programs. This discovery could enable future medical uses like targeted drug delivery and tissue regeneration, blurring the boundary between life and death.

Animal Study Signals Potential One-Dose Cure for Osteoarthritis
health3 months ago

Animal Study Signals Potential One-Dose Cure for Osteoarthritis

Colorado researchers report two regenerative approaches for osteoarthritis: a single, injectable therapy using a repurposed FDA-approved drug with a patented particle delivery system, and an engineered protein cocktail that patches cartilage by recruiting the body’s progenitor cells. In animal models, treated joints regained health within 4–8 weeks, and human cells from joint-replacement patients showed regenerative effects in vitro. Having completed Phase I, the team moves to Phase II under ARPA-H’s $30 million NITRO program, aiming for clinical trials in about 18 months and the potential for an affordable, single‑visit therapy to repair joints and avoid replacements.

Stem-derived retinal vessels repair damaged retinas in mice, paving way for new eye therapies
science3 months ago

Stem-derived retinal vessels repair damaged retinas in mice, paving way for new eye therapies

Duke researchers derived retinal endothelial cells from human iPSCs, generated lab-grown retinal vasculature, and showed these cells can integrate into diseased mouse retina to rebuild vessels and restore barrier function, offering a scalable model for studying eye diseases and a potential preventative therapy.

Epigenetic Rejuvenation in the Eye Sets Stage for Reversing Blindness
science3 months ago

Epigenetic Rejuvenation in the Eye Sets Stage for Reversing Blindness

Scientists report that epigenetic reprogramming to revive youthful cellular memory in aging eye cells has reached humans, with the first patient treated in a Phase 1 trial for glaucoma and other optic neuropathies. The approach could someday restore some lost vision, but safety, delivery, and how durable the effects are remain major hurdles before it becomes a widely available therapy.